Back to Browse Journals

Neuropsychiatric Disease and Treatment


Dr Pinder

Pharma, Independent Pharma Consultant, United Kingdom

Dr Pinder

Editor-in-Chief:  Dr Roger M. Pinder, PhD, DSc

Dr Pinder is an independent pharma consultant based in the city of York in the UK. He advises and consults worldwide to several pharmaceutical and venture capital organizations. He is founding editor of Neuropsychiatric Disease and Treatment and of the International Journal of Wine Research. He has served as president and secretary of the International Society for Affective Disorders (ISAD), and as treasurer and councillor of the International College of Neuropsychopharmacology (CINP).

Educated in the UK and the USA at the universities of Hull and Virginia, Dr Pinder holds doctoral degrees in medicinal chemistry (PhD) and neuropsychopharmacology (DSc). He is a fellow of the British Pharmacological Society, the British Association for Psychopharmacology, the European (ECNP) and the International Colleges of Neuropsychopharmacology (CINP), and of ISAD, and serves on the editorial board of Medicinal Chemistry Research. His professional research interests include cardiovascular and CNS pharmacology and therapeutics, with a special emphasis on depressive disorders, anti-depressants and the health benefits of wine. He is a regular speaker and chair at international congresses, and has published five books and more than 250 review and research articles.

After a long career in R&D and medical affairs management in the international pharmaceutical industry, DrPinder is now a board member of a number of start-up pharmaceutical companies.


Dr Kishi

Department of Psychiatry, Fujita Health University School of Medicine, Japan

Dr Kishi

Associate Editor - Japan: Dr Taro Kishi

Dr. Kishi has been practicing at the Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan, since 2002. In 2010 and 2011, he spent two years as a postdoctoral research fellow at the Zucker Hillside Hospital in New York. Dr. Kishi is a senior lecturer at the Department of Psychiatry, Fujita Health University School of Medicine. Dr. Kishi has been performing a series of clinical trials for the treatment of schizophrenia and mood disorder. His research focus is also evidence-based medicine in schizophrenia and mood disorder with a focus on meta-analyses. Moreover, He has a research interest in psychiatric genetics, pharmacogenetics, compliance enhancement strategies and medical decision making. He has authored/co-authored more than 120 articles.


Professor Tang

Department of Psychiatry, The Chinese University of Hong Kong, Hong Kong

Professor Tang

Associate Editor - China: Professor Wai Kwong Tang

Professor WK Tang was appointed to Professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. Professor Tang completed his medical training at the Chinese University of Hong Kong, he then joined the Chinese University of Hong Kong as an academic staff in 1999. His main research area is Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong. 


Editorial Board

Hojjat Adeli, Professor, The Ohio State University, Columbus, OH, USA

Kristian Barlinn, Department of Neurology, University Hospital Carl Gustav Carus, Dresden, Germany

Marlene Oscar Berman, Professor of Psychiatry, Neurology, Anatomy and Neurobiology, Boston University School of Medicine, Boston, Massachusetts, USA

Joseph R Calabrese, Professor of Psychiatry, Case Western Reserve University, Cleveland, USA

Sandra Chan, Associate Professor, Department of Psychiatry, The Chinese University of Hong Kong, Hong Kong

Dr. Lin Chen, MD. & Ph.D. Associate Chief Physician, Department of Neurosurgery, Tsinghua University and Yuquan Hospital, People’s Republic of China

Wai-Tong Chien, Professor, School of Nursing, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Hong Kong SAR

Francesco Craig, Child Neuropsychiatry Unit, Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari “Aldo Moro”, Italy

Anthony David, Professor of Cognitive Neuropsychiatry, Kings College, London, UK

Andrea Fagiolini, Professor of Psychiatry, Chairman, Department of Mental Health, University of Siena School of Medicine, Italy

Mike Isaac, Consultant and Hon Senior Lecturer in Psychiatry, South London & Maudsley NHS FT and University of London, UK

Andrey Iznak, Professor, Mental Health Research Centre, Moscow, Russia

Sidney H Kennedy, Professor and Arthur Sommer Rotenberg Chair in Depression and Suicide Studies, St. Michael’s Hospital and University of Toronto, Canada

Firas Kobeissy, Asst Rsrch Prof, Assoc Scientific Dir of Psychoproteomics & Nanotechnology Rsrch Ctr, Dept of Psychiatry, The Evelyn F & William L McKnight Brain Institute, University of Florida, Gainesville, FL, USA

Michael Krausz, Professor, Department of Psychiatry, The University of British Columbia, Vancouver, BC, Canada

John S Markowitz, Professor, Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, FL, USA

Peter R. Martin, M.D., Professor of Psychiatry and Behavioral Sciences, Professor of Pharmacology, Vanderbilt Psychiatric Hospital, Vanderbilt University School of Medicine, Nashville, TN, USA

Julien Mendlewicz, Professor, Free University of Brussels, Brussels, Belgium

Shinichi Mitsui, Professor, Department of Rehabilitation Sciences, Gunma University Graduate School of Health Sciences, Gunma, Japan

Zoran M Pavlovic, CEO, Neuropassion KG, Heidelberg, Germany

George Perry, Dean, College of Sciences, University of Texas at San Antonio, San Antonio, TX, USA

Steven Potkin, Professor, University of California, Irvine, USA

Norman Sartorius, MD, PhD, FRCpsych, President, Association for the Improvement of Mental Health Programmes, Switzerland

Alessandro Serretti, MD, PhD, Department of Biomedical and NeuroMotor Sciences, University of Bologna, Italy

Haowei Shen, Ph.D., National Institute on Drug Dependence, Peking University, Beijing, People's Republic of China

Timo Siepmann, Research Physician, Department of Neurology, University Hospital Carl Gustav Carus; Program Director, Master's Program in Clinical Research, Dresden International University; Postdoctoral Researcher, Oxford Cardiovascular Clinical Research Facility, University of Oxford, Oxford, United Kingdom;

Edoardo Spina, Professor of Pharmacology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Eduard Vieta, Professor and Director of Research, Clinical Institute of Neuroscience, Hospital Clinic, University of Barcelona, Spain

Jinhuan Wang, Professor in neurosurgery, Director of Tianjin Huanhu Hospital and Tianjin Neurosurgery Institute, Tianjin, People's Republic of China

Ng Beng Yeong, Consultant Psychiatrist, Mount Elizabeth Medical Centre, Singapore

Nathan Zasler, CEO & Medical Director for Concussion Care Centre of Virginia, Ltd., and CEO & Medical Director for Tree of Life Services, Inc.; Clinical Professor, Department of PM&R, Virginia Commonwealth University, and Clinical Associate Professor, Department of PM&R, University of Virginia, Charlottesville, Virginia, USA